Month: February 2025

We often hear about the incredible advancements that shape the future—6G networks, quantum computing, artificial intelligence (AI), and more. But behind these cutting-edge innovations lies a key question that many may overlook: Who owns the future of these technologies? The answer lies in Standard Essential Patents (SEPs). These patents are the cornerstones of emerging standards… Continue reading Who Owns the Future of SEPs? Mapping Patents for 6G, Quantum Computing, and Beyond

Imagine a world where navigating the labyrinth of Standard Essential Patents (SEPs) doesn’t feel like a high-stakes game of negotiation, where licensing agreements are so clear and accessible that disputes are almost nonexistent. Sounds like a dream, right? But what if the technology that powers cryptocurrencies, like blockchain, could be the key to making this… Continue reading Can Blockchain Make SEP Licensing Easier and More Transparent

In the ever-evolving world of technology, patents are the backbone of innovation. They allow inventors and companies to protect their unique ideas, ensuring they can benefit from their hard work. But, have you ever wondered about Standard Essential Patents (SEPs)? These patents play a particularly crucial role in the tech industry, and understanding how to… Continue reading How to Accurately Value SEPs While Keeping FRAND Commitments in Check

In the fast-paced world of biopharmaceuticals, staying ahead of patent expirations and the rise of biosimilars is crucial for maintaining a competitive edge. For biopharma companies, understanding the nuances of patent law and biosimilar regulations is not just important—it’s essential to safeguard investments, drive innovation, and plan future strategies. One of the key tools that… Continue reading The Purple Book Demystified: What Biopharma Companies Need to Know About Patent Expirations and Biosimilars